BLBD
Blue Bird Corporation
BLBD has the edge over GME overall, supported by lower modeled downside and stronger modeled upside.
GME
GameStop Corp.
GME offers stronger fundamentals, but that advantage does not outweigh its weaker overall profile.
BLBD Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Healthy | |
| Healthy | |
| Strong |
BLBD's revenue, profitability, cash flow and balance sheet are all currently healthy.
GME Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Strong | |
| Strong | |
| Unavailable |
GME's profitability and cash flow are currently strong, and its revenue is stable. There isn't enough data to rate its balance sheet.
BLBD PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 6.8x | $55.45 | — |
| Cheap | 13x | $103 | +85% |
| Forward | 13x | $55.45 | — |
| Fair | 17x | $138 | +150% |
| Expensive | 39x | $320 | +476% |
Historical ranges are pointers, not guarantees.
BLBD has the edge over GME in the historical PE scenario, which offers more potential upside but is not a forecast.
GME PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 17x | $25.62 | — |
| Cheap | 18x | $27.96 | +9.1% |
| Forward | 38x | $25.62 | — |
| Fair | 43x | $66.84 | +161% |
| Expensive | 252x | $388 | +1414% |
Historical ranges are pointers, not guarantees.
GME's PE is in its cheap range at 17x. Analysts expect earnings to fall, which would put today's price at 38x next year's earnings, in its fair range.
BLBD Forward outlook
| Metric | Outlook |
|---|---|
| Strongly deteriorating | |
| Stable | |
| Growth | |
| Strongly weakening | |
| Limited | |
| High |
BLBD has the edge over GME on the outlook, with more favorable earnings and revenue expectations.
GME Forward outlook
| Metric | Outlook |
|---|---|
| Strongly deteriorating | |
| Strong decline | |
| Strong decline | |
| Strongly weakening | |
| Limited | |
| High |
Analysts expect GME's earnings and revenue to decline, with profitability weakening.
BLBD Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $4.42 | -46% |
| Q2 2026 | $8.22 | +136% |
| Q1 2026 | $4.07 | +27% |
| Q4 2025 | $3.96 | +23% |
| Q3 2025 | $3.88 | +23% |
| Q2 2025 | $3.48 | +15% |
| Q1 2025 | $3.21 | +30% |
| Q4 2024 | $3.21 | +69% |
| Q3 2024 | $3.16 | +327% |
BLBD's earnings per share have climbed steadily: $8.22 over the past year, up 136% from the year before, and higher year over year for 13 quarters in a row. Its recent earnings include one-off gains.
GME Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $0.67 | -56% |
| Q3 2026 | $1.54 | +93% |
| Q2 2026 | $1.34 | +153% |
| Q1 2026 | $0.77 | +133% |
| Q4 2025 | $0.89 | +394% |
| Q3 2025 | $0.80 | +515% |
| Q2 2025 | $0.53 | +563% |
| Q1 2025 | $0.33 | +1550% |
| Q4 2024 | $0.18 | +$0.21 |
GME's earnings per share have climbed steadily: $1.54 over the past year, up 93% from the year before, and higher year over year for 15 quarters in a row.
BLBD Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $517.2M | +30% |
| Q1 2026 | $352.6M | -1.7% |
| Q4 2025 | $333.1M | +6.1% |
| Q3 2025 | $409.4M | +17% |
| Q2 2025 | $398M | +19% |
| Q1 2025 | $358.9M | +3.7% |
| Q4 2024 | $313.9M | -1.2% |
| Q3 2024 | $350.2M | +16% |
BLBD has the edge over GME on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | 12% | -0.5 points |
| Q1 2026 | 11% | +1.7 points |
| Q4 2025 | 11% | +0.8 points |
| Q3 2025 | 12% | +5 points |
| Q2 2025 | 13% | +0.7 points |
| Q1 2025 | 9.4% | -1 points |
| Q4 2024 | 11% | -1.4 points |
| Q3 2024 | 7.3% | -2.3 points |
BLBD's operating margin was 12% last quarter, about level with the same quarter a year ago.
GME Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $790.2M | -19% |
| Q2 2026 | $835.3M | +14% |
| Q1 2026 | $1.1B | -14% |
| Q4 2025 | $821M | -4.6% |
| Q3 2025 | $972.2M | +22% |
| Q2 2025 | $732.4M | -17% |
| Q1 2025 | $1.3B | -28% |
| Q4 2024 | $860.3M | -20% |
GME's revenue has slid since its 2022 peak: $790M last quarter, down 19% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 20% | +13 points |
| Q2 2026 | 17% | +19 points |
| Q1 2026 | 12% | +6 points |
| Q4 2025 | 5% | +8.9 points |
| Q3 2025 | 6.8% | +9.6 points |
| Q2 2025 | -1.5% | +4.3 points |
| Q1 2025 | 6.2% | +3.1 points |
| Q4 2024 | -3.9% | -2.5 points |
GME has the edge over BLBD on profitability, with a higher operating margin.
BLBD Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | $21.7M | -59% |
| Q1 2026 | $39.9M | +113% |
| Q4 2025 | $31.1M | +43% |
| Q3 2025 | $60.5M | +20% |
| Q2 2025 | $52.3M | +$55.8M |
| Q1 2025 | $18.7M | -64% |
| Q4 2024 | $21.8M | +$24.5M |
| Q3 2024 | $50.2M | +49% |
BLBD generated $153M in free cash flow over the past year, up 7% from the year before.
GME Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $60.7M | -46% |
| Q2 2026 | $332.9M | +76% |
| Q1 2026 | $187.4M | +18% |
| Q4 2025 | $107M | +435% |
| Q3 2025 | $113.3M | +73% |
| Q2 2025 | $189.6M | +$304.3M |
| Q1 2025 | $158.8M | +$177.5M |
| Q4 2024 | $20M | +80% |
GME has the edge over BLBD on cash flow, with more consistent year-over-year improvement.
BLBD Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +8.4% | +2.7M shares |
| 1 year | +7.9% | +2.6M shares |
| 3 years | +7.8% | +2.6M shares |
| 5 years | +28% | +7.7M shares |
| Available history | +30% | +8.1M shares |
BLBD has the edge over GME on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q2 2026 | — |
| Q1 2026 | $198,000 |
| Q4 2025 | $2.4M |
| Q3 2025 | $5.5M |
| Q2 2025 | — |
| Q1 2025 | $3M |
| Q4 2024 | $1.4M |
| Q3 2024 | $877,000 |
BLBD spent $8M buying back its own shares over the past year, up 52% from the year before.
GME Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.1% | +300K shares |
| 1 year | +8.4% | +46.1M shares |
| 3 years | +94% | +288M shares |
| 5 years | +104% | +302M shares |
| Available history | +80% | +264M shares |
GME has 593M diluted shares, up 8.4% from a year ago.
| Quarter | Spent |
|---|---|
| Q1 2021 | — |
| Q4 2020 | — |
| Q1 2020 | $21.8M |
| Q4 2019 | $114M |
BLBD Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q2 2026 | -0.1x | Net Cash |
| Q1 2026 | -1.0x | Net Cash |
| Q4 2025 | -0.8x | Net Cash |
| Q3 2025 | -0.8x | Net Cash |
| Q2 2025 | -0.5x | Net Cash |
| Q1 2025 | -0.3x | Net Cash |
| Q4 2024 | -0.3x | Net Cash |
| Q3 2024 | -0.2x | Net Cash |
BLBD has more cash than debt.
GME Net Leverage
BLBD Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 39.4 | Neutral |
| Stochastic | 8.2 | Oversold |
BLBD's weekly RSI is 39 (neutral) and its Stochastic is 8 (oversold).
GME Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 59.9 | Neutral |
| Stochastic | 68.5 | Neutral |
GME's weekly RSI is 60 (neutral) and its Stochastic is 69 (neutral).
BLBD PE vs Consumer Cyclical Sector
| Metric | BLBD | Sector median | Relative |
|---|---|---|---|
| PE | 6.8x | 18x | 63% below |
| PE % | 0 | 47 | 47 pts below |
BLBD has the edge over GME on valuation relative to its sector.
GME PE vs Consumer Cyclical Sector
| Metric | GME | Sector median | Relative |
|---|---|---|---|
| PE | 17x | 18x | 7.7% below |
| PE % | 15 | 47 | 32 pts below |
GME is trading at 17x earnings, in line with the Consumer Cyclical sector's median of 18x.
BLBD Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $56.9 | 2.6% below |
| 20 week MA | $63.9 | 13% below |
| 50 week MA | $61.2 | 9.4% below |
| 100 week MA | $52.7 | 5.1% above |
| 200 week MA | $42.1 | 32% above |
BLBD has pulled back, but its long-term trend is still up: it's below its 8-, 20- and 50-week averages, but 32% above its 200-week average.
GME Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $25.2 | 1.8% above |
| 20 week MA | $22.4 | 15% above |
| 50 week MA | $22.6 | 13% above |
| 100 week MA | $24.0 | 7% above |
| 200 week MA | $21.8 | 17% above |
GME has the edge over BLBD on trend strength, trading above more of its moving averages.
BLBD Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $23.0 | $19.1 | -17% |
| 2021 | $19.1 | $14.7 | -23% |
| 2022 | $14.7 | $9.97 | -32% |
| 2023 | $9.97 | $27.0 | +170% |
| 2024 | $27.0 | $39.4 | +46% |
| 2025 | $39.4 | $50.7 | +29% |
| 2026 YTD | $50.7 | $55.5 | +9.3% |
BLBD has finished lower in three of the last six years. It's up 9.3% so far in 2026.
GME Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $1.48 | $5.04 | +241% |
| 2021 | $5.04 | $38.0 | +655% |
| 2022 | $38.0 | $20.1 | -47% |
| 2023 | $20.1 | $17.5 | -13% |
| 2024 | $17.5 | $32.2 | +84% |
| 2025 | $32.2 | $21.1 | -35% |
| 2026 YTD | $21.1 | $25.6 | +21% |
GME has the edge over BLBD on returns for 2026, with the stronger performance.